Human nasopharyngeal carcinoma cells (CNE2 Luc) (HeLa contaminated cell line, currently not for sale)

The application of Human nasopharyngeal carcinoma cells (CNE2 Luc) is primarily found in cancer research where these cells serve as a critical model for studying the biology and treatment of nasopharyngeal carcinoma thereby illuminating the underlying mechanisms of this malignancy As a highly characterized adherent cell line CNE2 Luc can be utilized to evaluate the efficacy of new therapies including targeted drugs and immunotherapies offering insights into potential treatment responses in human patients

Moreover the CNE2 Luc cell line is instrumental in drug screening and toxicity assays allowing researchers to assess the safety and effectiveness of novel compounds in a controlled environment which is vital for advancing cancer therapeutics Additionally the ability to preserve and transport these cells through dry ice ensures that they maintain viability for experimental use facilitating collaboration and enabling researchers worldwide to investigate nasopharyngeal carcinoma with consistency and reliability Overall the CNE2 Luc cell line exemplifies a robust tool for advancing our understanding of cancer biology and enhancing therapeutic interventions